Amperity is the AI-powered Customer Data Cloud that helps brands act on real-time customer context. By connecting data, decisions, and action, it enables more relevant experiences in the moments that matter. More than 400 brands worldwide rely on Amperity, including Alaska Airlines, DICK'S Sporting Goods, BECU, Virgin Atlantic, and Wyndham Hotels & Resorts. Founded in 2016, the company operates globally with offices in Seattle, New York City, London, and Melbourne.
BioSerenity is an international medical device and service company that develops smart healthcare solutions and provides telehealth services.
Our company is headquartered in Paris, France. We work closely with hospital doctors and researchers from across the world, and provide the medical community with the best tools for optimal patient care.
With our technical expertise and our networks from industrial and scientific partnerships, BioSerenity has provided high quality protective equipment to healthcare professionals throughout the fight against Covid-19.
We manufacture medical-grade surgical masks and FFP2-grade personal protective equipment (PPE) masks. As our DNA dictates, we had to add a touch of innovation along the way!
Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer’s disease.
Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer’s disease and expects to start pivotal studies in 2022. The company’s technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT.